BioSpace News Archive

First Publication Emerges from Company’s Multi-year Research Collaboration with Yale’s Division of Neurocognition, Neurocomputation, and Neurogenetics

Adlai Nortye Biopharma Co., Ltd. announced that Lars E. Birgerson, M.D., Ph.D., joins the company as Chief Development Officer (CDO) and President & CEO of Adlai Nortye USA Inc on July 1st.

Crunch Franchise announced today the planned opening of a new 24,000-square foot, 24/7 gym with state-of-the-art equipment and amenities in Waco, Texas.

DotBio, a new company focused on the development of novel immuno-oncology drugs based on humanized domain antibodies, has officially launched and has successfully raised US$2.3 million in seed financing led by the HeungKong Group via Futec Biomedical Investments Limited.

Arix Bioscience plc (LSE: ARIX), a global healthcare and life science company supporting medical innovation, today announces that it has acquired an 11 per cent interest in Pharmaxis Ltd (ASX: PXS), an Australian pharmaceutical research company focused on inflammation and fibrosis with a portfolio of products at various stages of development and approval.

Laboratoris Sanifit S.L., a clinical-stage biopharmaceutical company focused on treatments for calcification disorders, today announced the completion of enrollment of its Phase 2b CaLIPSO clinical trial investigating Sanifit’s lead candidate SNF472, for the treatment of cardiovascular calcification (CVC) in end-stage-renal-disease (ESRD) patients on haemodialysis (HD).

ASLAN Pharmaceuticals reported financial results for the quarter ended 30 June 2018 and provided an update on its clinical activities.

Neosanté Health Solutions raises awareness for babies and newborns suffering from episodes of irritability, agitation and crying for National Breastfeeding Awareness Month in August.

The purchase price for this transaction consisted of cash, in addition to warrants.

Upfront and milestone payments total up to $74.5M plus double-digit royalties